Huntsman Corp (HUN) concluded trading on Wednesday at a closing price of $12.85, with 3.73 million shares of worth about $47.95 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.69% during that period and on April 16, 2025 the price saw a loss of about -1.91%. Currently the company’s common shares owned by public are about 172.14M shares, out of which, 163.93M shares are available for trading.
Stock saw a price change of -9.89% in past 5 days and over the past one month there was a price change of -26.32%. Year-to-date (YTD), HUN shares are showing a performance of -28.73% which decreased to -46.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $11.90 but also hit the highest price of $25.92 during that period. The average intraday trading volume for Huntsman Corp shares is 3.44 million. The stock is currently trading -12.50% below its 20-day simple moving average (SMA20), while that difference is down -20.52% for SMA50 and it goes to -34.73% lower than SMA200.
Huntsman Corp (NYSE: HUN) currently have 172.14M outstanding shares and institutions hold larger chunk of about 86.30% of that.
The stock has a current market capitalization of $2.23B and its 3Y-monthly beta is at 0.86. It has posted earnings per share of -$0.94 in the same period. It has Quick Ratio of 0.77 while making debt-to-equity ratio of 0.76. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HUN, volatility over the week remained 5.65% while standing at 6.24% over the month.
Stock’s fiscal year EPS is expected to rise by 145.77% while it is estimated to increase by 1648.45% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on April 15, 2025 offering a Neutral rating for the stock and assigned a target price of $15 to it. On June 07, 2024, JP Morgan Upgrade their recommendations, while on February 23, 2024, Wells Fargo Upgrade their ratings for the stock with a price target of $32. Stock get an Equal-weight rating from Morgan Stanley on December 11, 2023.
